| || |
A native of Atlanta, Georgia, he earned his Bachelor’s degree from Duke University with a major in Mathematics. Dr. Beech continued his studies at the Medical College of Virginia in Richmond, Virginia where he received his Doctor of Medicine degree. Following medical school training, he received his residency training in Surgery at Temple University Hospital and Clinics in Philadelphia, Pennsylvania. During his residency training, Dr. Beech developed a strong interest in cancer surgery and the compassionate care required in the care of cancer patients. As such, he went on to complete his fellowship training in Surgical Oncology at M.D. Anderson Cancer Center in Houston, Texas.
Dr. Beech has received numerous honors and awards including membership in the Phi Kappa Phi Honor Society, Alpha Omega Alpha Honor Medical Society and Who’s Who in Medicine and Healthcare. He is a diplomat of the American Board of Surgery and a Fellow of the American College of Surgeons.
Dr. Beech has been actively involved in medical education and clinical practice as a faculty at Tulane University, New Orleans, Louisiana and the University of Tennessee at Memphis where he served as Chief of Surgical Oncology and Assistant Dean for Faculty Affairs. He previously served as Professor and Chairman of Surgery at Meharry Medical College, and Chief of Surgery at Nashville General Hospital at Meharry. He is currently Professor of Surgery and Senior Associate Dean of Clinical Affairs and Faculty Development at Morehouse School of Medicine.
He is a member of multiple national scientific organizations including the American College of Surgeons, American Association of Cancer Education and Cancer Research. He is a respected author in the field of surgery with over 170 manuscripts, book chapters, and abstracts. He has delivered over 90 local and national presentations and served as visiting professor at many leading institutions.
Dr. Beech’s research has focused on cancer prevention and control, novel gene therapy for cancer and large scale clinical trials with a special emphasis on breast cancer, sarcoma and colorectal cancer. He has coordinated prostate cancer prevention programs in western and middle Tennessee. He is an active investigator in prostate cancer prevention clinical trials and serves as Deputy Director of the Morehouse Cancer Program.